All In Biotech

Drug Trial Radar · NCT07621809

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

A Randomized, Double-blind, Placebo-controlled, 2-arm Multicenter Phase III Study to Assess the Efficacy and Safety of Ianalumab in Participants With Sjogren's Disease With High Symptom Burden (THALASSA)

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 570 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

570

Planned (sponsor's estimate)

Start

Jul 16, 2026

Primary completion

Aug 15, 2029

Study completion Aug 14, 2033

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Jun 2, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate the efficacy and safety of ianalumab (VAY736) 300 mg administered subcutaneously (s.c.) monthly for 52 weeks in adult participants with Sjögren's disease who have high symptom burden.

Conditions

  • Sjögren´s Disease

Interventions

  • VAY736Drug

    VAY736 once monthly solution for injection for subcutaneous use.

  • PlaceboDrug

    Placebo once monthly solution for injection for subcutaneous use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in SSSD oral dryness scoreTime frame: Baseline to Week 52

Locations

72 sites in 20 countries. Site status is shown where the registry gives one.

  • Sun Valley Arthritis Center Ltd

    Peoria, Arizona · Recruiting

  • Unity Health Rheumatology

    Searcy, Arkansas · Recruiting

  • Medvin Clinical Research

    Van Nuys, California · Recruiting

  • Clinical Res Of W Florida

    Clearwater, Florida · Recruiting

  • GNP Research

    Cooper City, Florida · Recruiting

  • Clinical Research of West Florida Inc

    Tampa, Florida · Recruiting

  • Willow Rheumatology Wellness

    Willowbrook, Illinois · Recruiting

  • Tufts Medical Center

    Boston, Massachusetts · Recruiting

  • Clinical Research Inst of MI

    Saint Clair Shores, Michigan · Recruiting

  • Arthritis Rheumatology and Bone Disease Associates PA

    Voorhees Township, New Jersey · Recruiting

  • St Lawrence Health System

    Potsdam, New York · Recruiting

  • On Site Clinical Solutions Llc

    Charlotte, North Carolina · Recruiting

  • Carolina Arthritis Associates

    Wilmington, North Carolina · Recruiting

  • RAO Research LLC

    Oklahoma City, Oklahoma · Recruiting

  • West Tennessee Research Institute

    Jackson, Tennessee · Recruiting

  • Shelby Research LLC

    Memphis, Tennessee · Recruiting

  • Novel Research LLC

    Bellaire, Texas · Recruiting

  • Arthritis Care of Texas

    Corpus Christi, Texas · Recruiting

  • Precision Comprehensive Clinical Research Solutions

    Euless, Texas · Recruiting

  • Abigail Neiman MD PA

    Houston, Texas · Recruiting

  • Accurate Clinical Research

    League City, Texas · Recruiting

  • TEKTON

    Leander, Texas · Recruiting

  • Arthritis Northwest PLLC

    Spokane, Washington · Recruiting

  • Novartis Investigative Site

    Maroochydore, Queensland, Australia · Recruiting

  • Novartis Investigative Site

    Graz, Austria · Recruiting

  • Novartis Investigative Site

    São Paulo, São Paulo, Brazil · Recruiting

  • Novartis Investigative Site

    Sydney, Nova Scotia, Canada · Recruiting

  • Novartis Investigative Site

    Rimouski, Quebec, Canada · Recruiting

  • Novartis Investigative Site

    Sherbrooke, Quebec, Canada · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

  • Novartis Investigative Site

    Jiujiang, China · Recruiting

  • Novartis Investigative Site

    Shenzhen, Guangdong, China · Recruiting

  • Novartis Investigative Site

    Nanjing, Jiangsu, China · Recruiting

  • Novartis Investigative Site

    Taiyuan, Shanxi, China · Recruiting

  • Novartis Investigative Site

    Chengdu, Sichuan, China · Recruiting

  • Novartis Investigative Site

    Wenzhou, Zhejiang, China · Recruiting

  • Novartis Investigative Site

    Ningbo, Zhengjiang, China · Recruiting

  • Novartis Investigative Site

    Bogotá, Colombia · Recruiting

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.